Skip to content
10-K

Annual Report

Luckwel Pharmaceuticals Inc.

0001493152-21-022312

← back to feed
Filed
Sep 9, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Aug 31, 2021 147.16M sh
Operating Cash Flow FY 2021 · Mar 31, 2021 −$197.98K
Operating Cash Flow restated FY 2021 · Mar 31, 2020 −$318.21K
Cash And Equivalents FY 2021 · Mar 31, 2021 $2.04K
Cash And Equivalents FY 2021 · Mar 31, 2020 $44
Stockholders Equity FY 2021 · Mar 31, 2021 −$444.27K
Stockholders Equity FY 2021 · Mar 31, 2020 −$1.33M
Stockholders Equity FY 2021 · Mar 31, 2019 −$791.82K
Total Liabilities FY 2021 · Mar 31, 2021 $490.95K
Total Liabilities FY 2021 · Mar 31, 2020 $1.35M
Total Assets FY 2021 · Mar 31, 2021 $46.68K
Total Assets FY 2021 · Mar 31, 2020 $17.21K
Sga Expense FY 2021 · Mar 31, 2021 $434.98K
Sga Expense FY 2021 · Mar 31, 2020 $536.43K
Net Income FY 2021 · Mar 31, 2021 −$436.01K
Net Income FY 2021 · Mar 31, 2020 −$536.43K